ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,000, issued on Sept. 16, was assigned to THE BROAD INSTITUTE INC. (Cambridge, Mass.), MASSACHUETTS INSTITUTE OF TECHNOLOGY (Cambridge, Mass.) and PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, N.C.).

"CRISPR system based antiviral therapy" was invented by Feng Zhang (Cambridge, Mass.), Jonathan S. Gootenberg (Cambridge, Mass.), Omar O. Abudayyeh (Cambridge, Mass.), Pardis Sabeti (Cambridge, Mass.), Cameron Myhrvold (Cambridge, Mass.) and Catherine Amanda Freije (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention offers a new approach for highly multiplexed, programmable antiviral therapies that directly targ...